| Name | Title | Contact Details |
|---|
Since our founding 10 years ago, we`ve always been a different kind of company. After moving to New York from his native Turkey, our CEO Hamdi Ulukaya thought everyone deserved better options, so he set about making delicious, nutritious, natural, and accessible Greek Yogurt right here in the U.S. Our mission since day one has been to provide better food to more people. And now as the No. 1-selling Greek Yogurt brand in America and the second largest overall yogurt manufacturer, we believe every food maker has a responsibility to provide people with better options, which is why we`re so proud of the way our food is made. From the very first batch that came off the line in Upstate New York, in 2007, our cups have been crafted using only natural, non-GMO ingredients. We refuse to use any preservatives. Our yogurt contains no artificial flavors, artificial sweeteners, or preservatives. It has been a busy 10 years for Chobani. Along our journey, we`ve constantly innovated our offerings to evolve with customer tastes and preferences, leading with values, and putting our people first. As we look to the future, Chobani is reinvigorating its founding mission with a vision to make universal wellness happen sooner using food as a force of good. Our vision builds on the company`s founding mission to provide better food for more people, while laying out how Chobani is defining wellness and where the brand will invest to achieve it: • Nutritional Wellness: Scaling our efforts to provide better food for more people. • Social Wellness: Increasing our investment in the communities we serve and the people who craft our food. • Environmental Wellness: Building a supply chain that ensures the planet`s health. This evolution supports Chobani`s ambition to become a food-focused wellness company and providing better food to all people.
We know you care about the future of food, and so do we. That`s why our experienced teams of ingredient specialists, technical experts, bakers, and culinary creators are working to develop innovative products that feed the world today and nourish what comes next for tomorrow. At the center of our efforts is a collaborative approach that brings the best of human insight, hard work, and trusted nutrition together to help our customers – and the future of nutrition – grow.
The Del Monte Corporation, doing business as Del Monte Foods, is an American food production and distribution company headquartered in One Maritime Plaza, San Francisco, California. Del Monte Foods is one of the country's largest producers, distributors and marketers of branded food and pet products for the U.S. retail market, generating approximately $3.6 billion in net sales in fiscal 2009. Its portfolio of brands includes Del Monte, S&W, Contadina, College Inn, Meow Mix, Kibbles 'n Bits, 9Lives, Milk-Bone, Pup-Peroni, Meaty Bone, Snausages and Pounce. Several Del Monte products hold the number one or two market share position. The company also produces, distributes and markets private label food and pet products.
Silver Eagle Beverages is committed to delivering the best beer & beverages in the business throughout San Antonio and South Texas. You must be 21+ to follow us
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.